EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Sodium Pyruvate Nasal Spray Reduces the Severity of Nasal Inflammation and Congestion in Patients with Allergic Rhinitis

Alain Martin, Christopher Lupfer iD, Ronald Amen

Journal of Aerosol Medicine and Pulmonary Drug Delivery · 01.12.2022 · 35 (6) · 291-295

DOI: 10.1089/jamp.2022.0025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Aerosol Medicine and Pulmonary Drug Delivery, online erschienen am 13.12.2022. Verfasst von Alain Martin und 2 weiteren Autor:innen. Beteiligte Einrichtung: EmphyCorp/Cellular Sciences, Inc., Flemington, New Jersey, USA. Hauptthemen laut MEDLINE: Rhinitis, Allergic, Rhinitis, Allergic, Seasonal. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

As an anti-inflammatory and antioxidant, sodium pyruvate significantly reduces inflammatory cytokines and oxygen radicals such as interleukin (IL) IL-6, IL-8, Monocyte Chemoattractant Protein-1, and hydrogen peroxide. Thus, sodium pyruvate holds promise as a treatment for many respiratory diseases, including allergic rhinitis (AR). Novel treatments for AR are needed as current medications, including steroids, often fail to treat severe symptoms.

Methods

The data from five human clinical studies were analyzed to determine the effect of 20 mM sodium pyruvate nasal spray (N115) in patients with AR. Nasal inflammation scores were compared to a placebo control or a no-treatment baseline control. Three studies were open-labeled and two were appropriately blinded to both patients and clinicians using computer randomization of subjects.

Results

The intranasal administration of sodium pyruvate significantly improved nasal inflammation scores in all five clinical trials of patients with AR ( p < 0.0001 in all trials).

Conclusions

These results give credence to the overall ability of sodium pyruvate, administered by nasal spray, to treat inflammation of the nasal airways.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rhinitis, AllergicRhinitis, Allergic, SeasonalHumansAdministration, InhalationAdministration, IntranasalInflammationNasal SpraysPyruvatesSodium

Stichwörter der Autor:innen

allergic rhinitisanti-inflammatoryinhaled pyruvate

Substanzen

Nasal SpraysPyruvatesSodium

Autor:innen und Institutionen

  • EmphyCorp/Cellular Sciences, Inc., Flemington, New Jersey, USA.
  • Department of Biology, Missouri State University, Springfield, Missouri, USA.

ORCID-Profile: Christopher Lupfer

Zitieren

APA

Martin, A., Lupfer, C., & Amen, R. (2022). Sodium Pyruvate Nasal Spray Reduces the Severity of Nasal Inflammation and Congestion in Patients with Allergic Rhinitis. Journal of Aerosol Medicine and Pulmonary Drug Delivery, 35(6), 291-295. https://doi.org/10.1089/jamp.2022.0025

Vancouver

Martin A, Lupfer C, Amen R. Sodium Pyruvate Nasal Spray Reduces the Severity of Nasal Inflammation and Congestion in Patients with Allergic Rhinitis. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 2022;35(6):291-295. doi:10.1089/jamp.2022.0025

BibTeX
@article{Martin2022,
  author = {Martin, Alain and Lupfer, Christopher and Amen, Ronald},
  title = {Sodium Pyruvate Nasal Spray Reduces the Severity of Nasal Inflammation and Congestion in Patients with Allergic Rhinitis},
  journal = {Journal of Aerosol Medicine and Pulmonary Drug Delivery},
  year = {2022},
  volume = {35},
  number = {6},
  pages = {291--295},
  doi = {10.1089/jamp.2022.0025}
}
Kostenlos starten →